UCLA medical school sued for allegedly using race-based admissions policy
UCLA medical school sued for allegedly using race-based admissions policy
An organization that opposes diversity initiatives in medicine sued UCLA‘s medical school Thursday, alleging in Los Angeles federal court that the school still employs a race-based admissions process despite a 2023 U.S. Supreme Court ruling that such programs for college admissions are unconstitutional.
The proposed class-action lawsuit brought by Do No Harm against the David Geffen School of Medicine contends that UCLA continues to practice “race-conscious” admissions under the guise of “holistic admissions” and ignores federal law by discriminating against applicants on the basis of race.
“Do No Harm is fighting for all the students who have been racially discriminated against by UCLA under the guise of political progress,” DNH founder Dr. Stanley Goldfarb said. “All medical schools must abide by the law of the land and prioritize merit, not immutable characteristics, in admissions.”
A message sent to UCLA seeking comment was not immediately answered.
Virginia-based DNH alleges that a white member of the organization was “unfairly rejected by Geffen, despite stellar academic achievements.” The group also contends that Geffen’s dean of admissions has both publicly and privately “said she uses race as a factor in making admission decisions.”
The organization further alleges that whistleblower accounts describe how the Geffen admissions committee “routinely gives Black and Latino applicants a pass for subpar metrics” and that “whites and Asians need near-perfect scores to even be considered.”
Goldfarb, a former dean at the University of Pennsylvania’s medical school and a retired kidney doctor, founded DNH three years ago “to safeguard health care from ideological threats,” the DNH website says.
With Beyoncé's Grammy Wins, Black Women in Country Are Finally Getting Their Due
February 17, 2025
Bad Bunny's "Debí Tirar Más Fotos" Tells Puerto Rico's History
February 17, 2025
Comments 0